Pacira BioSciences (PCRX) Depreciation and Depletion (2011 - 2026)

Pacira BioSciences' Depreciation and Depletion history runs 16 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion rose 2.94% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $33.9 million (up 40.08% YoY), while the FY2025 annual figure was $33.7 million, up 56.74% from the prior year.
• Depreciation and Depletion was $7.0 million for Q1 2026 at Pacira BioSciences, roughly flat from $7.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $16.2 million in Q4 2022 to a low of $4.1 million in Q3 2023.
• Historically, Depreciation and Depletion has averaged $6.7 million across 5 years, with a median of $6.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion surged 200.0% in 2022, then slumped 74.07% in 2023.
• A 5-year view of Depreciation and Depletion shows it stood at $16.2 million in 2022, then plunged by 74.07% to $4.2 million in 2023, then jumped by 64.29% to $6.9 million in 2024, then gained by 1.45% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
• The last three Depreciation and Depletion figures came in at $7.0 million (Q1 2026), $7.0 million (Q4 2025), and $6.9 million (Q3 2025), per Business Quant data.